ATE401060T1 - Schnell zerfallende tablette - Google Patents

Schnell zerfallende tablette

Info

Publication number: ATE401060T1
Authority: AT; Austria
Prior art keywords: tablets; years; dissolving tablet; pediatric patients; rapidly disintegrating
Prior art date: 2002-06-21

Application number

AT03760665T

Other languages

English (en)

Inventor

Vesna Skulj

Judita Sirca

Osel Jenko

Original Assignee

Lek Pharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-21

Filing date

2003-06-20

Publication date

2008-08-15

2003-06-20 Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals

2008-08-15 Application granted granted Critical

2008-08-15 Publication of ATE401060T1 publication Critical patent/ATE401060T1/de

Links

239000003826 tablet Substances 0.000 abstract 6
239000007919 dispersible tablet Substances 0.000 abstract 2
QJVHTELASVOWBE-AGNWQMPPSA-N (2s,5r,6r)-6-[[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2r,3z,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 QJVHTELASVOWBE-AGNWQMPPSA-N 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
229940088710 antibiotic agent Drugs 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT03760665T 2002-06-21 2003-06-20 Schnell zerfallende tablette ATE401060T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SI200200160A SI21221A (sl)	2002-06-21	2002-06-21	Hitro razpadljive tablete

Publications (1)

Publication Number	Publication Date
ATE401060T1 true ATE401060T1 (de)	2008-08-15

Family

ID=29778203

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03760665T ATE401060T1 (de)	2002-06-21	2003-06-20	Schnell zerfallende tablette

Country Status (9)

Country	Link
US (2)	US20060115528A1 (de)
EP (1)	EP1534245B1 (de)
AT (1)	ATE401060T1 (de)
AU (1)	AU2003249856A1 (de)
DE (1)	DE60322228D1 (de)
EA (1)	EA012324B1 (de)
PL (1)	PL206248B1 (de)
SI (2)	SI21221A (de)
WO (1)	WO2004000281A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040265375A1 (en) *	2003-04-16	2004-12-30	Platteeuw Johannes J.	Orally disintegrating tablets
NZ555909A (en) *	2004-12-13	2009-11-27	Mcneil Ppc Inc	Compositions and methods for reducing the degradation of phenylephrine by oxygen
WO2007058397A1 (en) *	2005-11-17	2007-05-24	Gl Pharmtech Corp.	A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same
TW200815020A (en) *	2006-06-15	2008-04-01	Serenex Inc	Stabilized tetracycline compositions
US9987257B2 (en) *	2012-01-10	2018-06-05	Michael Spector	Pediatric oral suspension formulations of amoxicillin and clavulanate potassium and method for using same
WO2013173803A2 (en) *	2012-05-17	2013-11-21	Michael Spector	Formulations of amoxicillin and clavulanate potassium and methods for using same
WO2013173808A2 (en) *	2012-05-17	2013-11-21	Michael Spector	Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
US9254261B2 (en)	2014-03-03	2016-02-09	Sandoz Ag	Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
US20160008310A1 (en)	2014-07-11	2016-01-14	Azanta A/S	Misoprostol dispersible tablet
NZ727876A (en)	2014-07-11	2018-05-25	Azanta Danmark As	Misoprostol dispersible tablet
CN104173601B (zh) *	2014-08-20	2017-11-07	黑龙江天翼药业有限公司	板蓝大青片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI9200139A (en) *	1992-07-08	1994-03-31	Lek Tovarna Farmacevtskih	New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
US5585115A (en) *	1995-01-09	1996-12-17	Edward H. Mendell Co., Inc.	Pharmaceutical excipient having improved compressability
DE69620607T2 (de) *	1995-06-22	2002-09-19	Akzo Nobel N.V., Arnheim/Arnhem	Trockengranulierte gepresste tabletten enthaltend desogestrel
GB9616536D0 (en) *	1996-08-06	1996-09-25	Quadrant Holdings Cambridge	Co-amoxiclav dosage form
US5985823A (en) *	1997-06-09	1999-11-16	Ambi Inc.	Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
US6350470B1 (en) *	1998-04-29	2002-02-26	Cima Labs Inc.	Effervescent drug delivery system for oral administration
US6200604B1 (en) *	1998-03-27	2001-03-13	Cima Labs Inc.	Sublingual buccal effervescent
US6368625B1 (en) *	1998-08-12	2002-04-09	Cima Labs Inc.	Orally disintegrable tablet forming a viscous slurry
US6117451A (en) *	1998-08-25	2000-09-12	Pharmalogix, Inc.	Direct compression metformin hydrochloride tablets
MXPA02005562A (es) *	1999-12-06	2004-09-10	Penwest Pharmaceuticals Co	Superdesintegrante farmaceutico.

2002
- 2002-06-21 SI SI200200160A patent/SI21221A/sl not_active IP Right Cessation
2003
- 2003-06-20 US US10/518,731 patent/US20060115528A1/en not_active Abandoned
- 2003-06-20 PL PL373034A patent/PL206248B1/pl unknown
- 2003-06-20 DE DE60322228T patent/DE60322228D1/de not_active Expired - Lifetime
- 2003-06-20 AT AT03760665T patent/ATE401060T1/de active
- 2003-06-20 WO PCT/EP2003/006528 patent/WO2004000281A1/en not_active Ceased
- 2003-06-20 AU AU2003249856A patent/AU2003249856A1/en not_active Abandoned
- 2003-06-20 EP EP03760665A patent/EP1534245B1/de not_active Expired - Lifetime
- 2003-06-20 EA EA200500031A patent/EA012324B1/ru not_active IP Right Cessation
- 2003-06-20 SI SI200331391T patent/SI1534245T1/sl unknown
2011
- 2011-10-07 US US13/269,050 patent/US20120028949A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL373034A1 (en)	2005-08-08
EA200500031A1 (ru)	2005-08-25
PL206248B1 (pl)	2010-07-30
US20120028949A1 (en)	2012-02-02
EP1534245A1 (de)	2005-06-01
WO2004000281A1 (en)	2003-12-31
US20060115528A1 (en)	2006-06-01
SI21221A (sl)	2003-12-31
EA012324B1 (ru)	2009-08-28
AU2003249856A1 (en)	2004-01-06
EP1534245B1 (de)	2008-07-16
DE60322228D1 (de)	2008-08-28
SI1534245T1 (sl)	2009-02-28

Similar Documents

Publication	Publication Date	Title
BR0313185A (pt)	2005-06-21	Probióticos para funções neuromusculares intestinais
EP2248519A3 (de)	2011-12-14	Nichtmukoadhäsive Filmdosierungsformen
EP0693281A3 (de)	1996-10-30	Pharmazeutische Zubereitungen, die Fluoxetin enthalten
TW200716208A (en)	2007-05-01	Modified and immediate release memantine bead formulation
TNSN07290A1 (en)	2008-12-31	Gastroresistant pharmaceutical formulations containing rifaximin
CA2472954A1 (en)	2003-08-07	Aza-arylpiperazines
TR200002541T2 (tr)	2001-03-21	Topiramatın farmasötik bilişimi
EA199800775A1 (ru)	1999-02-25	Таблетки, содержащие бетта-лактамный антибиотик, и способ их изготовления
TR200100756T2 (tr)	2001-07-23	Ajitasyondan etkilenmeyen çok-birimli uzun süreli salınımlı farmasötik preperatlar ve bunların üretim işleri
ATE401060T1 (de)	2008-08-15	Schnell zerfallende tablette
ATE298324T1 (de)	2005-07-15	Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
DE50005529D1 (de)	2004-04-08	Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BR0312728A (pt)	2005-04-26	Formulação em tablete dispersìvel e processo para sua preparação
NO20076405L (no)	2008-02-11	Anvendelse av 24-nor-UDCA
HUP0102159A2 (hu)	2002-01-28	Készítmény savtúltengés kezelésére
MY139086A (en)	2009-08-28	Use of debranched starch in extrusion-spheronization pharmaceutical pellets
ATE451340T1 (de)	2009-12-15	Deuterierte catecholaminderivate sowie diese verbindungen enthaltende arzneimittel
MY141008A (en)	2010-02-12	Oral formulations of deoxypeganine and their uses
WO2005056520A8 (en)	2005-09-15	Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
MD2211F1 (en)	2003-07-31	Remedy for treatment of parodontium affections
EA200101108A1 (ru)	2002-04-25	Полиморфные модификации кристаллического цитрата азабицикло[2.2.2]октан-3-амина и их фармацевтические композиции
ATE253555T1 (de)	2003-11-15	Vitamin d-analogen und ihre pharmazeutische verwendung
IL164763A0 (en)	2005-12-18	Byperforin derivatives, the use thereof and formulations containing them
TR200704897A1 (tr)	2009-02-23	Uzatılmış salım sağlayan gliklazid formülasyonları@
ES3014980T3 (en)	2025-04-28	Water dispersible mini-tablets comprising enalapril maleate for the treatment of hypertension in a pediatric population and method of preparation thereof

Legal Events

Date

Code

Title

Description

2009-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1534245

Country of ref document: EP